If you're considering a GLP-1 medication and want to start with a full evaluation instead of a shortcut, schedule a conversation with our team to talk through whether it's the right fit for your health.
We aim to fulfill the unmet needs of medical professionals and patients by developing a patch-type formulation of GLP-1 analogues, which are garnering global attention." About Daewoong Therapeutics Daewoong Therapeutics, a member of the Daewoong Group since February 2019, specializes in R&D for medical and pharmaceutical breakthroughs
Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
Research has shown that this effect is "mediated through adjustments in the reward pathway in the brain," he said
Willems M, Quartero AO, Numans ME
Wright AK, Carr MJ, Kontopantelis E et al (2022) Primary prevention of cardiovascular and heart failure events with SGLT2 inhibitors, GLP-1 receptor agonists, and their combination in type 2 diabetes